- Arrowhead Research (NASDAQ:ARWR) FQ1 results: Revenues: $43.8K (-74.4%); R&D Expense: $10.3M (-41.8%); SG&A: $2M (-4.8%); Net Loss: ($19.3M) (+14.6%); Loss Per Share: ($0.32) (+22.0%); Quick Assets: $76.6M (-22.5%).
- No guidance given.
Arrowhead Research net loss improves in FQ1
Recommended For You
More Trending News
About ARWR Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ARWR | - | - |
| Arrowhead Pharmaceuticals, Inc. | ||